AbbVie Biotechnology Ltd (manufacturing of medicinal product, testing, primary packaging)

The drug is used to treat adults with moderate to severe plaque psoriasis, as well as for the treatment of active psoriatic arthritis (either alone or in combination with methotrexate).

Dosage form: solution for injection

ATC: L04AC18